Does Internal Mammary Node Irradiation Have Survival Benefit for Clinical Stage, II-III Breast Cancer Patients After Neoadjuvant Chemotherapy?

被引：0
|
作者：
Kim, K. [1 ]
Noh, J. [2 ]
Kim, Y. [1 ]
Chang, J. [1 ]
Keum, K. [1 ]
Huh, S. [2 ]
Choi, D. [2 ]
Park, W. [2 ]
Suh, C. [1 ]
机构：
[1] Yonsei Univ, Coll Med, Severance Hosp, Dept Radiat Oncol, Seoul, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiat Oncol, Seoul, South Korea
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2014年 / 90卷
关键词：
D O I：
10.1016/j.ijrobp.2014.05.670
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1026
引用
收藏
页码：S168 / S168
页数：1
相关论文
共 50 条
  • [41] Evidence-based indications for post-mastectomy radiation after neoadjuvant chemotherapy for stage II-III breast cancer.
    Mayadev, J.
    Fowble, B.
    Einck, J. P.
    Kim, D.
    McCloskey, S.
    Yashar, C. M.
    Chen, S. L.
    Hwang, S. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (27)
  • [42] Optimal time for breast-conserving surgery after neoadjuvant chemotherapy in patients with stage II or III breast cancer
    Awad, Kerolos B. A.
    Kirollos, Andrew M. A.
    Awad, Philobater B. A.
    Hassan, Basma H. A.
    Shehab, Mohammed H.
    Fahmy, Karim
    Ahmed, Dina H.
    EGYPTIAN JOURNAL OF SURGERY, 2022, 41 (02): : 634 - 641
  • [43] Sentinel Lymph Node Biopsy is Precise After Primary Systemic Therapy in Stage II-III Breast Cancer Patients
    Reitsamer, Roland
    Menzel, Christian
    Glueck, Sylvia
    Rettenbacher, Lukas
    Weismann, Christian
    Hutarew, Georg
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 : S286 - S290
  • [44] Feasibility and outcomes of concurrent paclitaxel chemotherapy and radiotherapy for node-positive stage II-III breast cancer
    Chen, W. C.
    Kim, J.
    Kim, E.
    Silverman, P.
    Overmoyer, B.
    Cooper, B. W.
    Anthony, S.
    Shenk, R.
    Leeming, R.
    Lyons, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S169 - S169
  • [45] Neoadjuvant trastuzumab in a sequential nonanthracycline-based regimen for patients with stage II-III breast cancer
    Carillio, G.
    Aiello, R.
    Ali, M.
    Mazzola, A.
    Scandurra, G.
    Taibi, E.
    Chiarenza, M.
    Fallica, G.
    Caruso, F.
    Caruso, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [46] Breast-conserving surgery after neoadjuvant chemotherapy for stage III breast cancer patients
    Shin, Hee-Chul
    Han, Wonshik
    Moon, Hyeong-Gon
    Moon, Woo Kyung
    Im, Seock-Ah
    Kim, Tae-You
    Park, In-Ae
    Noh, Dong-Young
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [47] Cyclin E as a prognostic marker and predictor of response to neoadjuvant chemotherapy and adjuvant hormonal therapy in patients with stage II-III breast cancer
    Karakas, Cansu
    Francis, Ashleigh
    Yi, Min
    Sahin, Aysegul
    Keyomarsi, Khandan
    Hunt, Kelly
    CANCER RESEARCH, 2015, 75
  • [48] Analysis of circulating tumor DNA after neoadjuvant therapy to predict disease relapse in patients with stage II-III breast cancer
    Lin, Po-Han
    Kuo, Sung-Sheng
    Huang, Chiun-Sheng
    CANCER RESEARCH, 2020, 80 (16)
  • [49] Pre-chemotherapy 18F-FDG PET/CT upstages nodal stage in stage II-III breast cancer patients treated with neoadjuvant chemotherapy
    Koolen, Bas B.
    Olmos, Renato A. Valdes
    Vogel, Wouter V.
    Peeters, Marie Jeanne T. F. D. Vrancken
    Rodenhuis, Sjoerd
    Rutgers, Emiel J. Th.
    Elkhuizen, Paula H. M.
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 141 (02) : 249 - 254
  • [50] Is Elective Nodal Irradiation Necessary in Patients With Negative Pathologic Lymph Node Status After Neoadjuvant Chemotherapy Followed by Breast Conserving Surgery for Clinically Stage II-III Breast Cancer?: A Multicenter Retrospective Study (KROG 12-05)
    Noh, J.
    Park, W.
    Huh, S.
    Shin, K.
    Suh, C.
    Kim, S.
    Shin, H.
    Keum, K.
    Kim, J.
    Lee, H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S199 - S199
12345